Notice Number: NOT-DA-14-031
Key Dates
Release Date: August 26, 2014
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse's participation, effective immediately, in PAR-14-321 "Developing Interventions for Health-Enhancing Physical Activity (R21/R33)."
The following sections of PAR-14-321 have been updated to reflect the participation of NIDA in this FOA.
Components of Participating Organizations
Division of Program Coordination, Planning and Strategic Initiatives, Office of
Disease Prevention (ODP)
National Cancer Institute (NCI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Center for Complementary and Alternative Medicine (NCCAM)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Research on Women’s Health (ORWH)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866; 93.399; 93.273; 93.213; 93.313; 93.279
Scientific/Research Contact(s)
Lisa Onken, Ph.D.
National Institute on Drug Abuse
Telephone: 301-443-2235
Email: Lisa.Onken@nih.gov
Financial/Grants Management Contact(s)
Diana Haikalis
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-1373
Email: diana.haikalis@nih.gov
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Lisa Onken, Ph.D.
National Institute on Drug Abuse
Telephone: 301-443-2235
Email: Lisa.Onken@nih.gov